It’s now clear that the Supreme Court’s ruling in Dobbs last year raised more questions than it answered. The latest example of this came late last Friday when a pair of opinions from federal judges threw the legality of a long-used abortion medication into doubt.
Listen here and subscribe to On The Merits on Apple Podcasts, Spotify, Google Podcasts, Megaphone, or Audible.
A judge from Washington state ordered the FDA to maintain the status quo for the drug mifepristone. Another judge from Texas came to the opposite conclusion, ordering the FDA to ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.